Inventor
VERGNAULT GUY
FR22 patents
⚠️ This page may combine multiple inventors who share the name “VERGNAULT GUY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JAGOTEC AG
10 patentsUS6027748AFeb 22, 2000
Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption
JAGOTEC AG194 citations98
US6221395B1Apr 24, 2001
Controlled release pharmaceutical tablets containing an active principle of low water solubility
JAGOTEC AG76 citations95
US9622980B2Apr 18, 2017
Controlled release compositions
JAGOTEC AG5 citations83
US8003690B2Aug 23, 2011
Topical nanoparticulate spironolactone formulation
JAGOTEC AG9 citations79
US7838028B2Nov 23, 2010
Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, and respective processes of producing same and a cup-shaped envelope of same
JAGOTEC AG8 citations79
US7927624B2Apr 19, 2011
Hydrophilic/lipophilic polymeric matrix dosage formulation
JAGOTEC AG5 citations74
US9186332B2Nov 17, 2015
Delayed release tablet with defined core geometry
JAGOTEC AG1 citations61
US9040085B2May 26, 2015
Delayed release tablet with defined core geometry
JAGOTEC AG1 citations61
US10076500B2Sep 18, 2018
Floating gastric retentive dosage form
JAGOTEC AG1 citations51
US9884021B2Feb 6, 2018
Delayed release tablet with defined core geometry
JAGOTEC AG0 citations51
VERGNAULT GUY
7 patentsUS8394407B2Mar 12, 2013
Delayed release tablet with defined core geometry
VERGNAULT GUY14 citations91
US8168218B2May 1, 2012
Delayed release tablet with defined core geometry
VERGNAULT GUY16 citations91
US8460706B2Jun 11, 2013
Hydrophilic/lipophilic polymeric matrix dosage formulation
VERGNAULT GUY8 citations83
US8309124B2Nov 13, 2012
Delayed release tablet with defined core geometry
VERGNAULT GUY5 citations72
US8303986B2Nov 6, 2012
Hydrophilic/lipophilic polymeric matrix dosage formulation
VERGNAULT GUY2 citations62
US8927608B2Jan 6, 2015
Compositions comprising amphetamin and lisdexamfetamine
VERGNAULT GUY0 citations51
US8697755B2Apr 15, 2014
Beta 2 adrenergic receptor agonists such as terbutaline for use in the treatment of nocturnal hypoglycemia
VERGNAULT GUY0 citations51
GRENIER PASCAL
4 patentsUS9101544B2Aug 11, 2015
Controlled release nisoldipine compositions
GRENIER PASCAL2 citations60
US9314430B2Apr 19, 2016
Floating gastric retentive dosage form
GRENIER PASCAL1 citations50
US8663693B2Mar 4, 2014
Nanoparticulate formulations of fenofibrate
GRENIER PASCAL0 citations50
US8980363B2Mar 17, 2015
Method and apparatus for producing a centred compression coated tablet
GRENIER PASCAL0 citations40